Cargando…

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department

Detalles Bibliográficos
Autores principales:	Dhokar, R., Ghazali, H., Chermiti, I., Ben Abessia, H., Ben Garfa, A., Keskes, S., Tagougui, A., Souissi, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164594/ http://dx.doi.org/10.1016/j.diabres.2022.109329

Ejemplares similares

EHMTI-0273. Onabotulinotoxin type A is a therapeutic option in chronic cluster headache
por: Mas-Sala, N, et al.
Publicado: (2014)

P02.73. Optimal healing environment in a continuing care retirement community: a feasibility study
por: Najm, W, et al.
Publicado: (2012)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

IDF21-0353 Covid19 toe, a late manifestation of mild SARS-CoV-2 with Diabetes
por: Jain, R., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

IDF21-0427 Gender differences in age, new onset vs established diabetes in patients with Covid in an urban healthcare centre in India
por: Sriram, U., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

Gastrointestinal manifestations of diabetic ketoacidosis.
por: Barrett, E. J., et al.
Publicado: (1983)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

The Heroes of the I.D.F.
por: Gotweter, Y.
Publicado: (1967)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0542 Sharing “a.ma.dia” Experiences of how the Institution Have Faced COVID-19 Issues
por: Ramamonjisoa, H.A., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19
por: Inamdar, A., et al.
Publicado: (2022)

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects
por: Baidya, A., et al.
Publicado: (2022)

Diabetic Ketoacidosis: An Uncommon Manifestation of Pesticide Poisoning
por: Swaminathan, Krishnan, et al.
Publicado: (2013)

Ketoacidosis as a primary manifestation of COVID-19
por: Akbarizadeh, Majid Reza, et al.
Publicado: (2021)

IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes
por: Munda, A., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0302 A human digital interface uniquely supports diabetes patient care during COVID 19
por: Mehrotra, R.N., et al.
Publicado: (2022)

IDF21-0160 Impact of COVID-19 on Health-Related Quality of Life and Glycemic Status of Type 1 Diabetes Children in Kuwait
por: Alqaisi, T., et al.
Publicado: (2022)

IDF21-0234 The Virtual COVID In-patient (VCIP) Care and Post Covid Symptoms: a Comparison with Conventional Care
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis
por: Juangco, J.R., et al.
Publicado: (2022)

IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)

IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination
por: Kanzy, A., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0t9kpholpstii0okge584484v3